All In MedTech

Device Trial Radar · NCT07464353

xDot Access Management System Early Feasibility Study

xDot Access Management System Early Feasibility Study for Closure of Large Bore Femoral-Arterial & Venous-Access Sites

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jun 16, 2026

Primary completion

Aug 2026

Study completion Aug 2026

Sponsor

Lead sponsor
xDot Medical, IncNot on our public-company list
Sponsor type
Industry
Collaborators
Bright Research Partners
First posted
Mar 11, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to demonstrate safety and investigate effectiveness of the xDot Access Management System (AMS) for closure of large bore femoral-arterial and femoral-venous access sites.

Conditions

  • Vascular Closure Devices

Interventions

  • xDot Access Management System (AMS)Device

    The xDot AMS is designed to deliver the xDot Implant Unit in the anterior wall of the target vessel to close the puncture site.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from major complications of the target access siteTime frame: 30 days post-procedure
  2. Time to hemostasis (TTH)Time frame: During procedure

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Advocate Good Samaritan Hospital

    Downers Grove, Illinois · Recruiting

  • CentraCare Heart and Vascular Center

    Saint Cloud, Minnesota · Recruiting

  • Oklahoma Heart Institute

    Tulsa, Oklahoma · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.